[(2R,3R,4S,5R,6R)-2-(phenylcarbamoyloxymethyl)-4,5-bis(phenylmethoxy)-6-propan-2-yloxyoxan-3-yl] acetate

C32H37NO8 — CID 101052532

IUPAC[(2R,3R,4S,5R,6R)-2-(phenylcarbamoyloxymethyl)-4,5-bis(phenylmethoxy)-6-propan-2-yloxyoxan-3-yl] acetate
SMILESCC(=O)O[C@H]1[C@H](OCc2ccccc2)[C@@H](OCc2ccccc2)[C@H](OC(C)C)O[C@@H]1COC(=O)Nc1ccccc1
InChIInChI=1S/C32H37NO8/c1-22(2)39-31-30(37-20-25-15-9-5-10-16-25)29(36-19-24-13-7-4-8-14-24)28(40-23(3)34)27(41-31)21-38-32(35)33-26-17-11-6-12-18-26/h4-18,22,27-31H,19-21H2,1-3H3,(H,33,35)/t27-,28-,29+,30-,31-/m1/s1
InChIKeyIYVDZRBPZLWKDO-PXPWAULYSA-N
MW563.65 g/mol
LogP5.49
Rot. Bonds12

About [(2R,3R,4S,5R,6R)-2-(phenylcarbamoyloxymethyl)-4,5-bis(phenylmethoxy)-6-propan-2-yloxyoxan-3-yl] acetate

[(2R,3R,4S,5R,6R)-2-(phenylcarbamoyloxymethyl)-4,5-bis(phenylmethoxy)-6-propan-2-yloxyoxan-3-yl] acetate (PubChem CID 101052532) has the molecular formula C32H37NO8 and a molecular weight of 563.65 g/mol. Its IUPAC name is [(2R,3R,4S,5R,6R)-2-(phenylcarbamoyloxymethyl)-4,5-bis(phenylmethoxy)-6-propan-2-yloxyoxan-3-yl] acetate.

Molecular Properties

Compound Name[(2R,3R,4S,5R,6R)-2-(phenylcarbamoyloxymethyl)-4,5-bis(phenylmethoxy)-6-propan-2-yloxyoxan-3-yl] acetate
PubChem CID101052532
Molecular FormulaC32H37NO8
Molecular Weight563.65 g/mol
Exact Mass563.25
IUPAC Name[(2R,3R,4S,5R,6R)-2-(phenylcarbamoyloxymethyl)-4,5-bis(phenylmethoxy)-6-propan-2-yloxyoxan-3-yl] acetate
SMILESCC(=O)O[C@H]1[C@H](OCc2ccccc2)[C@@H](OCc2ccccc2)[C@H](OC(C)C)O[C@@H]1COC(=O)Nc1ccccc1
InChIInChI=1S/C32H37NO8/c1-22(2)39-31-30(37-20-25-15-9-5-10-16-25)29(36-19-24-13-7-4-8-14-24)28(40-23(3)34)27(41-31)21-38-32(35)33-26-17-11-6-12-18-26/h4-18,22,27-31H,19-21H2,1-3H3,(H,33,35)/t27-,28-,29+,30-,31-/m1/s1
InChIKeyIYVDZRBPZLWKDO-PXPWAULYSA-N
XLogP5.49
TPSA101.55 Ų
H-Bond Donors1
H-Bond Acceptors8
Rotatable Bonds12
Heavy Atoms41
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500563.65
LogP ≤ 55.49
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 108

Analyze [(2R,3R,4S,5R,6R)-2-(phenylcarbamoyloxymethyl)-4,5-bis(phenylmethoxy)-6-propan-2-yloxyoxan-3-yl] acetate with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of [(2R,3R,4S,5R,6R)-2-(phenylcarbamoyloxymethyl)-4,5-bis(phenylmethoxy)-6-propan-2-yloxyoxan-3-yl] acetate?
The IUPAC name of [(2R,3R,4S,5R,6R)-2-(phenylcarbamoyloxymethyl)-4,5-bis(phenylmethoxy)-6-propan-2-yloxyoxan-3-yl] acetate (CID 101052532) is [(2R,3R,4S,5R,6R)-2-(phenylcarbamoyloxymethyl)-4,5-bis(phenylmethoxy)-6-propan-2-yloxyoxan-3-yl] acetate.
What is the SMILES notation for [(2R,3R,4S,5R,6R)-2-(phenylcarbamoyloxymethyl)-4,5-bis(phenylmethoxy)-6-propan-2-yloxyoxan-3-yl] acetate?
The canonical SMILES for [(2R,3R,4S,5R,6R)-2-(phenylcarbamoyloxymethyl)-4,5-bis(phenylmethoxy)-6-propan-2-yloxyoxan-3-yl] acetate is CC(=O)O[C@H]1[C@H](OCc2ccccc2)[C@@H](OCc2ccccc2)[C@H](OC(C)C)O[C@@H]1COC(=O)Nc1ccccc1.
What is the InChIKey of [(2R,3R,4S,5R,6R)-2-(phenylcarbamoyloxymethyl)-4,5-bis(phenylmethoxy)-6-propan-2-yloxyoxan-3-yl] acetate?
The InChIKey is IYVDZRBPZLWKDO-PXPWAULYSA-N. The full InChI is InChI=1S/C32H37NO8/c1-22(2)39-31-30(37-20-25-15-9-5-10-16-25)29(36-19-24-13-7-4-8-14-24)28(40-23(3)34)27(41-31)21-38-32(35)33-26-17-11-6-12-18-26/h4-18,22,27-31H,19-21H2,1-3H3,(H,33,35)/t27-,28-,29+,30-,31-/m1/s1.
What are the key properties of [(2R,3R,4S,5R,6R)-2-(phenylcarbamoyloxymethyl)-4,5-bis(phenylmethoxy)-6-propan-2-yloxyoxan-3-yl] acetate?
[(2R,3R,4S,5R,6R)-2-(phenylcarbamoyloxymethyl)-4,5-bis(phenylmethoxy)-6-propan-2-yloxyoxan-3-yl] acetate has a molecular weight of 563.65 g/mol, XLogP of 5.49, 12 rotatable bonds, 1 hydrogen bond donors, and 8 hydrogen bond acceptors.
Where does this data come from?
All data for [(2R,3R,4S,5R,6R)-2-(phenylcarbamoyloxymethyl)-4,5-bis(phenylmethoxy)-6-propan-2-yloxyoxan-3-yl] acetate is sourced from PubChem (CID 101052532), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).